These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 14609759

  • 1. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C, Taieb J, Terme M, Maruyama K, Flament C, Angevin E, Zitvogel L.
    Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
    [Abstract] [Full Text] [Related]

  • 2. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
    Terunuma H, Deng X, Dewan Z, Fujimoto S, Yamamoto N.
    Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
    [Abstract] [Full Text] [Related]

  • 3. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer.
    Wesa AK, Storkus WJ.
    Cell Death Differ; 2008 Jan; 15(1):51-7. PubMed ID: 17948028
    [Abstract] [Full Text] [Related]

  • 4. NK cell receptors as tools in cancer immunotherapy.
    Sentman CL, Barber MA, Barber A, Zhang T.
    Adv Cancer Res; 2006 Jan; 95():249-92. PubMed ID: 16860660
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.
    Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L.
    Nat Med; 1999 Apr; 5(4):405-11. PubMed ID: 10202929
    [Abstract] [Full Text] [Related]

  • 6. Helper role of NK cells during the induction of anticancer responses by dendritic cells.
    Kalinski P, Giermasz A, Nakamura Y, Basse P, Storkus WJ, Kirkwood JM, Mailliard RB.
    Mol Immunol; 2005 Feb; 42(4):535-9. PubMed ID: 15607810
    [Abstract] [Full Text] [Related]

  • 7. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
    Mahmood S, Upreti D, Sow I, Amari A, Nandagopal S, Kung SK.
    Immunotherapy; 2015 Feb; 7(3):301-8. PubMed ID: 25804481
    [Abstract] [Full Text] [Related]

  • 8. Natural killer cells: biology and clinical use in cancer therapy.
    Hallett WH, Murphy WJ.
    Cell Mol Immunol; 2004 Feb; 1(1):12-21. PubMed ID: 16212916
    [Abstract] [Full Text] [Related]

  • 9. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
    Gros F, Cabillic F, Toutirais O, Maux AL, Sebti Y, Amiot L.
    Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
    [Abstract] [Full Text] [Related]

  • 10. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.
    Zwirner NW, Fuertes MB, Girart MV, Domaica CI, Rossi LE.
    Cytokine Growth Factor Rev; 2007 Mar; 18(1-2):159-70. PubMed ID: 17324607
    [Abstract] [Full Text] [Related]

  • 11. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS.
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [Abstract] [Full Text] [Related]

  • 12. Cross-talk between dendritic cells and natural killer cells in viral infection.
    Andrews DM, Andoniou CE, Scalzo AA, van Dommelen SL, Wallace ME, Smyth MJ, Degli-Esposti MA.
    Mol Immunol; 2005 Feb; 42(4):547-55. PubMed ID: 15607812
    [Abstract] [Full Text] [Related]

  • 13. NK cell regulation of T cell-mediated responses.
    Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier LL.
    Mol Immunol; 2005 Feb; 42(4):451-4. PubMed ID: 15607797
    [Abstract] [Full Text] [Related]

  • 14. Close encounters of different kinds: dendritic cells and NK cells take centre stage.
    Degli-Esposti MA, Smyth MJ.
    Nat Rev Immunol; 2005 Feb; 5(2):112-24. PubMed ID: 15688039
    [Abstract] [Full Text] [Related]

  • 15. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk.
    Fernandez NC, Flament C, Crépineau F, Angevin E, Vivier E, Zitvogel L.
    Eur Cytokine Netw; 2002 Feb; 13(1):17-27. PubMed ID: 11956017
    [Abstract] [Full Text] [Related]

  • 16. The 'kiss of death' by dendritic cells to cancer cells.
    Chan CW, Housseau F.
    Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
    [Abstract] [Full Text] [Related]

  • 17. Killer dendritic cells and their potential role in immunotherapy.
    Ullrich E, Chaput N, Zitvogel L.
    Horm Metab Res; 2008 Feb; 40(2):75-81. PubMed ID: 18283624
    [Abstract] [Full Text] [Related]

  • 18. BCR/ABL promotes dendritic cell-mediated natural killer cell activation.
    Terme M, Borg C, Guilhot F, Masurier C, Flament C, Wagner EF, Caillat-Zucman S, Bernheim A, Turhan AG, Caignard A, Zitvogel L.
    Cancer Res; 2005 Jul 15; 65(14):6409-17. PubMed ID: 16024645
    [Abstract] [Full Text] [Related]

  • 19. Pathogen-induced private conversations between natural killer and dendritic cells.
    Della Chiesa M, Sivori S, Castriconi R, Marcenaro E, Moretta A.
    Trends Microbiol; 2005 Mar 15; 13(3):128-36. PubMed ID: 15737731
    [Abstract] [Full Text] [Related]

  • 20. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L, Carbone DP.
    Adv Cancer Res; 2004 Mar 15; 92():13-27. PubMed ID: 15530555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.